GL - Latest News
Globe Life Inc. (GL), operates in Financial Services / Insurance - Life, trades on NYSE.
Market capitalization stands near $11.88B. Trailing twelve-month P/E ratio is 10.19. Beta to the broader market is 0.50.
The article list below shows the most recent GL headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent GL Headlines
Why Globe Life (GL) is a Top Momentum Stock for the Long-Term
zacks.com - May 13, 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
GL Stock Near 52-Week High: A Signal for Investors to Hold Tight?
zacks.com - May 11, 2026
Globe Life is set to grow on rising life and health premiums, stronger investment income and disciplined capital deployment.
Globe Life Inc. Declares Dividend
prnewswire.com - Apr 30, 2026
MCKINNEY, Texas, April 30, 2026 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) announced that its Board of Directors has declared a quarterly dividend of
Asset Management One Co. Ltd. Sells 10,518 Shares of Globe Life Inc. $GL
defenseworld.net - Apr 25, 2026
Asset Management One Co. Ltd.
Globe Life Inc (GL) Q1 2026 Earnings Call Highlights: Strong Net Operating Income and Strategic AI Initiatives
gurufocus.com - Apr 24, 2026
Net Income: $271 million, or $3. 39 per share, compared to $255 million, or $3.
How News Affects GL Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track GL's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked GL news questions
- What is the latest GL news headline?
- The most recent GL headline (May 13, 2026) is "Why Globe Life (GL) is a Top Momentum Stock for the Long-Term". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the GL news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What GL news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual GL options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.